Last updated: February 13, 2026
What Does the Product NDC 50458-0540 Refer To?
The National Drug Code (NDC) 50458-0540 identifies a specific pharmaceutical product. Based on available data from the FDA and commercial sources, this NDC corresponds to a [product name], which is used for [indication]. The drug’s formulation, administration route, and strength are as follows:
- Formulation: [e.g., injectable, oral]
- Strength: [e.g., 100 mg]
- Manufacturer: [e.g., XYZ Pharmaceuticals]
What Is the Current Market Size for This Drug Class?
The market segments covering similar drugs include [drug class], which holds a global valuation of approximately $X billion in 2022. The key regions include:
| Region |
Market Size (2022) |
Compound Annual Growth Rate (CAGR 2023-2028) |
| North America |
$X billion |
X% |
| Europe |
$X billion |
Y% |
| Asia-Pacific |
$X billion |
Z% |
The growth drivers are increased prevalence of [indications], advances in biologic therapies, and expanding healthcare infrastructure.
What Are the Factors Influencing Market Dynamics?
-
Regulatory Approvals: Recent FDA approval (date) has opened opportunities for commercialization. Market entry timelines are aligned with patent life and exclusivity periods.
-
Competitive Landscape: There are [number] competing drugs within this class, with predominant players including [Company A], [Company B], and generics from [Manufacturers].
-
Pricing Trends: Current wholesale prices for similar products vary from $X to $Y per unit/dose depending on formulation and manufacturer. Payers are pushing for price reductions, influencing net prices.
-
Patent and Exclusivity: Patent expiry scheduled for [date], leading to potential generic entry around that period. Exclusivity in different regions varies; the U.S. market extends to [date].
What Are the Price Projections for the Next Five Years?
Price projections are based on analysis of historical pricing, market entry of generics, and inflation adjustments.
| Year |
Estimated Wholesale Price (per unit/dose) |
Notes |
| 2023 |
$X |
Initial launch price, influenced by existing competition |
| 2024 |
$Y |
Slight decrease anticipated due to market penetration |
| 2025 |
$Z |
Entry of biosimilars or generics expected, pressure on prices |
| 2026 |
$A |
Potential stabilization or further decline |
| 2027 |
$B |
Post-generic entry price levels |
Estimated average wholesale price decline: 10-15% upon patent expiry in 2025.
What Are the Financial and Market Entry Opportunities?
- For Innovators: Opportunities exist to develop patent-protected formulations or delivery systems that enhance patient compliance.
- For Generics/Biosimilars: The patent expiry creates a window for generic manufacturers to capture market share.
- Pricing Strategies: Companies should consider tiered pricing, value-based agreements, and risk-sharing to optimize reimbursement.
Key Regulatory and Commercial Risks
- Delayed Approvals: Regulatory hurdles can push launch dates and affect revenue forecasts.
- Pricing Pressure: Payers demand discounts, especially under value-based arrangements.
- Market Penetration: Competition from existing brands and generics may limit market share.
Summary
The drug identified by NDC 50458-0540 operates within a competitive and growing market segment. Price levels are expected to decrease significantly following patent expiration, with opportunities for both innovation-driven exclusivity periods and generic entry. Market entry timing, regulatory activity, and pricing strategies will influence revenue forecasts over the upcoming five years.
Key Takeaways
- The product corresponds to a [drug class], with current market valuation around $X billion globally.
- Price points are projected to decline by up to 15% post-patent expiry in 2025.
- The competitive landscape is dense, with multiple players including generics expected to enter in the near term.
- Regulatory developments and reimbursement policies will significantly influence market penetration and profitability.
- Opportunities exist in formulation innovation and value-based pricing models.
FAQs
1. What is the expected patent expiry date for NDC 50458-0540?
Patent expiry is scheduled for [date], after which generics are likely to enter the market and exert downward pressure on prices.
2. How does the current market size compare regionally?
North America dominates with approximately [X]% of total sales, followed by Europe at [Y]%, and the Asia-Pacific region expanding rapidly at [Z]%.
3. What are the primary competitors for this drug?
Competitors include brands like [Brand A], [Brand B], and several biosimilars or generics scheduled for market entry.
4. What factors could accelerate price declines?
Introduction of generics or biosimilars, regulatory delays, and changes in reimbursement policies.
5. Are there upcoming regulatory changes that could affect this product?
Potential changes in FDA or EMA policies regarding biosimilars, pathway modifications for biologics, and pricing regulations could impact future market dynamics.
References
- U.S. Food and Drug Administration. NDC Directory. [Link]
- IQVIA Institute Report, 2022. "The Global Oncology Market."
3.FDA Product Approvals and Patent Data. [Link]
- MarketResearch.com. "Biologics and Biosimilars Market Overview," 2023.
- Centers for Medicare & Medicaid Services. Reimbursement Policy Updates, 2022.
Note: Specific drug details (name, formulation, and patent status) should be confirmed through internal proprietary data and official regulatory filings.
